Found: 5
Select item for more details and to access through your institution.
The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 58, n. 5, p. 1024
- By:
- Publication type:
- Article
Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 6, p. 1087, doi. 10.1093/jac/dki396
- By:
- Publication type:
- Article
High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study.
- Published in:
- Infection, 2020, v. 48, n. 3, p. 453, doi. 10.1007/s15010-020-01428-1
- By:
- Publication type:
- Article
Update on the "Choosing Wisely" initiative in infectious diseases in Germany.
- Published in:
- Infection, 2020, v. 48, n. 3, p. 317, doi. 10.1007/s15010-020-01400-z
- By:
- Publication type:
- Article
Use of bioelectrical impedance analysis to determine body composition changes in HIV-associated wasting.
- Published in:
- International Journal of STD & AIDS, 2005, v. 16, n. 4, p. 307, doi. 10.1258/0956462053654177
- By:
- Publication type:
- Article